The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy
Primary Purpose
Hysterectomy, Methylprednisolone, Postoperative Pain
Status
Completed
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
Methylprednisolone 125mg
Sodium Chloride 2 ml
Sponsored by

About this trial
This is an interventional prevention trial for Hysterectomy focused on measuring abdominal hysterectomy, glucocorticoids, rehabilitation, postoperative pain, analgetics
Eligibility Criteria
Inclusion Criteria:
- Patients having an abdominal hysterectomy on a benign indication.
- Patients who speak and understand Danish.
- Patients who can give informed consent.
Exclusion Criteria:
- Diabetics
- Regular use of glucocorticoids, opioids or tranquilizers
- Regular treatment with immunosuppressives
- Alcohol or drug abuse
- Morphine intolerance
- Age under 18
- Chronic pain disease eg fibromyalgia, rheumatoid arthritis
- Malign indication for hysterectomy
- BMI over 35
- Decreased kidney function
- ASA III or IV
Sites / Locations
- Department of Gynaechology and Obstetrics, Holbæk Sygehus
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Methylprednisolone
placebo/sodium chloride
Arm Description
Outcomes
Primary Outcome Measures
Pain 6 hours postoperatively
Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 6 hours postoperatively
Pain 3 hours postoperatively
Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 3 hours postoperatively
Pain 24 hours postoperatively
Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 24 hours postoperatively
Pain
Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest once daily from 2nd-7th postoperative day
Secondary Outcome Measures
Use of additional analgesics
The use of other analgesics than paracetamol and diclofenac postoperatively - dosage.
Postoperative nausea
Numbers of vomits
Use of antiemetics
Dosage of antiemetics during the first 2 days postoperatively
Time until mobilization
Time until discharge after surgery
Inflammatory parameters
CRP measured 0-24 hours preoperatively before injection of project medicine.
Adverse effects
Inflammatory parameter
CRP measured at 10am on the first and second postoperative day.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01106547
Brief Title
The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy
Official Title
The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy: A Prospective, Double Blinded, Placebo Controlled Study
Study Type
Interventional
2. Study Status
Record Verification Date
October 2011
Overall Recruitment Status
Completed
Study Start Date
August 2009 (undefined)
Primary Completion Date
September 2011 (Actual)
Study Completion Date
October 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Holbaek Sygehus
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to evaluate the effect of 125 mg methylprednisolone, given intravenously 60-90 minutes before abdominal surgery,on the postoperative rehabilitation after abdominal hysterectomy.Sodium Chloride is the placebo. The following parameters are registered:
Pain 3, 6 and 24 hours postoperatively and 2-7 days after surgery.
The postoperative use of additional analgesics.
Inflammatory parameters before and after surgery.
Time until mobilization.
Time until discharge.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hysterectomy, Methylprednisolone, Postoperative Pain
Keywords
abdominal hysterectomy, glucocorticoids, rehabilitation, postoperative pain, analgetics
7. Study Design
Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
55 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Methylprednisolone
Arm Type
Experimental
Arm Title
placebo/sodium chloride
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Methylprednisolone 125mg
Other Intervention Name(s)
Solu-medrol
Intervention Description
Single dose 60-90 minutes preoperatively
Intervention Type
Drug
Intervention Name(s)
Sodium Chloride 2 ml
Intervention Description
Single dose 60-90 min preoperatively
Primary Outcome Measure Information:
Title
Pain 6 hours postoperatively
Description
Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 6 hours postoperatively
Time Frame
6 hours postoperatively
Title
Pain 3 hours postoperatively
Description
Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 3 hours postoperatively
Time Frame
3 hours postoperatively
Title
Pain 24 hours postoperatively
Description
Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest 24 hours postoperatively
Time Frame
24 hours postoperatively
Title
Pain
Description
Pain registered by a score on a vas-scale from 0-10 during mobilization and during rest once daily from 2nd-7th postoperative day
Time Frame
2-7 days postoperatively
Secondary Outcome Measure Information:
Title
Use of additional analgesics
Description
The use of other analgesics than paracetamol and diclofenac postoperatively - dosage.
Time Frame
0-2 days
Title
Postoperative nausea
Description
Numbers of vomits
Time Frame
until 2 days postoperatively
Title
Use of antiemetics
Description
Dosage of antiemetics during the first 2 days postoperatively
Time Frame
0-2 days postoperatively
Title
Time until mobilization
Time Frame
0-2 days
Title
Time until discharge after surgery
Time Frame
0-10 days
Title
Inflammatory parameters
Description
CRP measured 0-24 hours preoperatively before injection of project medicine.
Time Frame
0-24 h preoperatively
Title
Adverse effects
Time Frame
0-2 days
Title
Inflammatory parameter
Description
CRP measured at 10am on the first and second postoperative day.
Time Frame
1-2 days postoperative
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patients having an abdominal hysterectomy on a benign indication.
Patients who speak and understand Danish.
Patients who can give informed consent.
Exclusion Criteria:
Diabetics
Regular use of glucocorticoids, opioids or tranquilizers
Regular treatment with immunosuppressives
Alcohol or drug abuse
Morphine intolerance
Age under 18
Chronic pain disease eg fibromyalgia, rheumatoid arthritis
Malign indication for hysterectomy
BMI over 35
Decreased kidney function
ASA III or IV
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Niels Jørgen Secher, Professor
Organizational Affiliation
Department of Obstetrics, Hvidovre Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Department of Gynaechology and Obstetrics, Holbæk Sygehus
City
Holbæk
ZIP/Postal Code
4300
Country
Denmark
12. IPD Sharing Statement
Citations:
Citation
Lidegaard O, Hammerum MS. Landspatientregisteret til kvalitetssikring i det gynækologiske speciale. 2002.
Results Reference
background
Citation
Danish hysterektomy database - year report 2004.
Results Reference
background
PubMed Identifier
11878721
Citation
Hall GM, Peerbhoy D, Shenkin A, Parker CJ, Salmon P. Relationship of the functional recovery after hip arthroplasty to the neuroendocrine and inflammatory responses. Br J Anaesth. 2001 Oct;87(4):537-42. doi: 10.1093/bja/87.4.537.
Results Reference
background
PubMed Identifier
10625002
Citation
Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg. 2000 Jan;90(1):186-94. doi: 10.1097/00000539-200001000-00038.
Results Reference
background
PubMed Identifier
10866900
Citation
Wang JJ, Ho ST, Tzeng JI, Tang CS. The effect of timing of dexamethasone administration on its efficacy as a prophylactic antiemetic for postoperative nausea and vomiting. Anesth Analg. 2000 Jul;91(1):136-9. doi: 10.1097/00000539-200007000-00025.
Results Reference
background
PubMed Identifier
10553859
Citation
Liu K, Hsu CC, Chia YY. The effective dose of dexamethasone for antiemesis after major gynecological surgery. Anesth Analg. 1999 Nov;89(5):1316-8.
Results Reference
background
PubMed Identifier
17850557
Citation
Kehlet H. Glucocorticoids for peri-operative analgesia: how far are we from general recommendations? Acta Anaesthesiol Scand. 2007 Oct;51(9):1133-5. doi: 10.1111/j.1399-6576.2007.01459.x. No abstract available.
Results Reference
background
PubMed Identifier
16757774
Citation
Salerno A, Hermann R. Efficacy and safety of steroid use for postoperative pain relief. Update and review of the medical literature. J Bone Joint Surg Am. 2006 Jun;88(6):1361-72. doi: 10.2106/JBJS.D.03018.
Results Reference
background
PubMed Identifier
14578725
Citation
Bisgaard T, Klarskov B, Kehlet H, Rosenberg J. Preoperative dexamethasone improves surgical outcome after laparoscopic cholecystectomy: a randomized double-blind placebo-controlled trial. Ann Surg. 2003 Nov;238(5):651-60. doi: 10.1097/01.sla.0000094390.82352.cb.
Results Reference
background
PubMed Identifier
15504180
Citation
Romundstad L, Breivik H, Niemi G, Helle A, Stubhaug A. Methylprednisolone intravenously 1 day after surgery has sustained analgesic and opioid-sparing effects. Acta Anaesthesiol Scand. 2004 Nov;48(10):1223-31. doi: 10.1111/j.1399-6576.2004.00480.x.
Results Reference
background
PubMed Identifier
10574107
Citation
Nagelschmidt M, Fu ZX, Saad S, Dimmeler S, Neugebauer E. Preoperative high dose methylprednisolone improves patients outcome after abdominal surgery. Eur J Surg. 1999 Oct;165(10):971-8. doi: 10.1080/110241599750008107.
Results Reference
background
PubMed Identifier
12437261
Citation
Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2002 Nov;195(5):694-712. doi: 10.1016/s1072-7515(02)01491-6. No abstract available.
Results Reference
background
PubMed Identifier
11085349
Citation
Sauerland S, Nagelschmidt M, Mallmann P, Neugebauer EA. Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review. Drug Saf. 2000 Nov;23(5):449-61. doi: 10.2165/00002018-200023050-00007.
Results Reference
background
PubMed Identifier
19076108
Citation
Mathiesen O, Rasmussen ML, Dierking G, Lech K, Hilsted KL, Fomsgaard JS, Lose G, Dahl JB. Pregabalin and dexamethasone in combination with paracetamol for postoperative pain control after abdominal hysterectomy. A randomized clinical trial. Acta Anaesthesiol Scand. 2009 Feb;53(2):227-35. doi: 10.1111/j.1399-6576.2008.01821.x. Epub 2008 Dec 6.
Results Reference
background
PubMed Identifier
25058804
Citation
Celik C, Tasdemir N, Abali R, Bastu E, Akbaba E, Yucel SH, Gul A. The effect of uterine straightening by bladder distention before outpatient hysteroscopy: a randomised clinical trial. Eur J Obstet Gynecol Reprod Biol. 2014 Sep;180:89-92. doi: 10.1016/j.ejogrb.2014.06.029. Epub 2014 Jul 7.
Results Reference
derived
PubMed Identifier
25058803
Citation
Aabakke AJ, Holst LB, Jorgensen JC, Secher NJ. The effect of a preoperative single-dose methylprednisolone on postoperative pain after abdominal hysterectomy: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2014 Sep;180:83-8. doi: 10.1016/j.ejogrb.2014.06.026. Epub 2014 Jul 7.
Results Reference
derived
Learn more about this trial
The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy
We'll reach out to this number within 24 hrs